Barclays analyst Alex Sloane upgraded Givaudan (GVDNY) to Equal Weight from Underweight with a price target of CHF 4,000, up from CHF 3,800. The firm sees the company as a key potential beneficiary from stepped-up reformulation from 2026 amid the shift to phase out synthetic colors and other ingredients in the U.S.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GVDNY: